SCHEMBL6937459

SCHEMBL6937459

Cc1c(C2CCCCO2)ccc2c(O)cc(=O)oc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 4/20 0.45
MET P08581 1/20 0.44
MAOA P21397 4/20 0.41
CA12 O43570 8/20 0.40
CA9 Q16790 8/20 0.40
TNF P01375 1/20 0.40
NOD2 Q9HC29 1/20 0.40
NOD1 Q9Y239 1/20 0.40
POLB P06746 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
GAA P10253 4/20 0.39
KDM4E B2RXH2 3/20 0.39
ALDH1A1 P00352 3/20 0.39
MAPK1 P28482 2/20 0.39
LMNA P02545 2/20 0.39
MGAM O43451 1/20 0.39
TP53 P04637 1/20 0.39
CYP3A4 P08684 1/20 0.39
MAPT P10636 1/20 0.39
SI P14410 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6867070 0.79 MAOB (0.51) MAOBMETMAOAGAAKDM4E
SCHEMBL7741637 0.79 ALDH1A1 (0.36) MAOBMAOAPOLBGAAKDM4E
SCHEMBL6934958 0.76 KDM4E (0.42) MAOBMAOACA12CA9TNF
SCHEMBL5345045 0.73 MAOB (0.77) MAOBMETCA12CA9TNF
SCHEMBL5346589 0.72 MAOB (0.65) MAOBMETMAOACA12CA9
SCHEMBL7056849 0.69 POLB (0.34) POLBLMNATP53MAPTHPGD
SCHEMBL5725956 0.68 TRPA1 (0.38) POLBGAAKDM4EALDH1A1LMNA
SCHEMBL8442563 0.67 HPGD (0.72) MAOBMETMAOAPOLBGAA
SCHEMBL23258722 0.67 MAP3K14 (0.35) POLBGAAKDM4EALDH1A1TP53
SCHEMBL23250685 0.67 MAP3K14 (0.35) POLBGAAKDM4EALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6579902-B1 Antibiotic; ethoxy-carbamic acid 3'-ester of N-(7-((6-deoxy-5-C-methyl-4-O- methyl-alpha-L-lyxo-hexopyranosyl)oxy)-4-hydroxy-8-methyl-2-oxo-2H-1 -benzopyran-3-yl)-benzeneacetamide AVENTIS PHARMA S.A. (FR) 2003-06-17 US disclosed
EP-1045856-B1 NOVEL AROMATIC AMIDES, PREPARATION METHOD AND APPLICATION AS MEDICINES AVENTIS PHARMA SA (FR) 2003-04-09 EP disclosed
US-20030060609-A1 Novel aromatic amides, preparation method and application as medicines AVENTIS PHARMA S.A. 2003-03-27 US disclosed
EP-1173455-A2 NOVEL RIBOSE-SUBSTITUTED AROMATIC AMIDES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS Aventis Pharma S.A. (FR) 2002-01-23 EP disclosed
WO-2000063222-A2 NOVEL RIBOSE-SUBSTITUTED AROMATIC AMIDES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS AVENTIS PHARMA S.A. (FR) 2000-10-26 WO disclosed
EP-1045856-A1 NOVEL AROMATIC AMIDES, PREPARATION METHOD AND APPLICATION AS MEDICINES HOECHST MARION ROUSSEL (FR) 2000-10-25 EP disclosed
WO-1999035155-A1 NOVEL AROMATIC AMIDES, PREPARATION METHOD AND APPLICATION AS MEDICINES HOECHST MARION ROUSSEL (FR) 1999-07-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030060609-A1 Novel aromatic amides, preparation method and application as medicines NRDC, NPR1, NR4A1 MAOB 1323/4885MET 559/4885MAOA 1019/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.